Performance of SCORE2 and SCORE2-OP risk algorithms in a Cypriot cohort.

IF 1.5 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Andrew N Nicolaides, Maura Griffin, Andrie G Panayiotou, Theodosis Tyllis, Dawn Bond, Niki Georgiou, Efthyvoulos Kyriacou, Costantinos Avraamides, Richard M Martin
{"title":"Performance of SCORE2 and SCORE2-OP risk algorithms in a Cypriot cohort.","authors":"Andrew N Nicolaides,&nbsp;Maura Griffin,&nbsp;Andrie G Panayiotou,&nbsp;Theodosis Tyllis,&nbsp;Dawn Bond,&nbsp;Niki Georgiou,&nbsp;Efthyvoulos Kyriacou,&nbsp;Costantinos Avraamides,&nbsp;Richard M Martin","doi":"10.23736/S0392-9590.22.04958-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>SCORE2 and SCORE2-OP algorithms and associated online calculators provide a new and easy method of estimating the 10-year cardiovascular risk in apparently healthy Europeans. The aim of the study was to determine the performance of these algorithms in terms of discrimination and calibration in the cohort of the Cyprus Epidemiological Study on Atherosclerosis (CESA), not only for the 10-year risk for myocardial infarction (MI), stroke and cardiovascular death, but also for all types of atherosclerotic cardiovascular events (ASCVE).</p><p><strong>Methods: </strong>SCORE2 and SCORE2-OP for low-risk regions were calculated in a non-diabetic subset of CESA consisting of 908 people (mean age±SD: 57.8±10.5; range 40-89; 58.8% female) using baseline risk factors. Mean follow-up was 13.2±3.7 years (range 1-17) with 89 primary endpoints (MI, stroke and cardiovascular death) and 136 secondary endpoints (primary endpoints, angina, cardiac failure, coronary revascularization, transient ischemic attack, claudication and critical limb ischemia).</p><p><strong>Results: </strong>The C-statistic for the prediction of the primary endpoint for all ages was 0.76 (95% CI 0.70 to 0.81) and the observed 10-year event rate was similar to the predicted one. However, the observed 10-year rate for secondary events was similar to the estimated one only when the algorithm for high-risk regions was used.</p><p><strong>Conclusions: </strong>SCORE2 and SCORE2-OP moderate risk algorithms perform well in the Cypriot population for predicting the 10-year risk for MI, stroke and fatal cardiovascular disease. However, an estimate of the 10-year risk for all ASCVD events is best calculated from the high-risk algorithm.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Angiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S0392-9590.22.04958-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: SCORE2 and SCORE2-OP algorithms and associated online calculators provide a new and easy method of estimating the 10-year cardiovascular risk in apparently healthy Europeans. The aim of the study was to determine the performance of these algorithms in terms of discrimination and calibration in the cohort of the Cyprus Epidemiological Study on Atherosclerosis (CESA), not only for the 10-year risk for myocardial infarction (MI), stroke and cardiovascular death, but also for all types of atherosclerotic cardiovascular events (ASCVE).

Methods: SCORE2 and SCORE2-OP for low-risk regions were calculated in a non-diabetic subset of CESA consisting of 908 people (mean age±SD: 57.8±10.5; range 40-89; 58.8% female) using baseline risk factors. Mean follow-up was 13.2±3.7 years (range 1-17) with 89 primary endpoints (MI, stroke and cardiovascular death) and 136 secondary endpoints (primary endpoints, angina, cardiac failure, coronary revascularization, transient ischemic attack, claudication and critical limb ischemia).

Results: The C-statistic for the prediction of the primary endpoint for all ages was 0.76 (95% CI 0.70 to 0.81) and the observed 10-year event rate was similar to the predicted one. However, the observed 10-year rate for secondary events was similar to the estimated one only when the algorithm for high-risk regions was used.

Conclusions: SCORE2 and SCORE2-OP moderate risk algorithms perform well in the Cypriot population for predicting the 10-year risk for MI, stroke and fatal cardiovascular disease. However, an estimate of the 10-year risk for all ASCVD events is best calculated from the high-risk algorithm.

SCORE2和SCORE2- op风险算法在塞浦路斯队列中的表现。
背景:SCORE2和SCORE2- op算法和相关的在线计算器提供了一种新的、简单的方法来估计表面健康的欧洲人10年心血管风险。该研究的目的是在塞浦路斯动脉粥样硬化流行病学研究(CESA)队列中确定这些算法在区分和校准方面的性能,不仅适用于心肌梗死(MI)、中风和心血管死亡的10年风险,而且适用于所有类型的动脉粥样硬化性心血管事件(ASCVE)。方法:计算908例CESA非糖尿病亚组低危区SCORE2和SCORE2- op(平均年龄±SD: 57.8±10.5;射程40 - 89;58.8%女性),使用基线危险因素。平均随访时间为13.2±3.7年(范围1-17年),89个主要终点(心肌梗死、卒中和心血管死亡)和136个次要终点(主要终点,心绞痛、心力衰竭、冠状动脉血运重建术、短暂性脑缺血发作、跛行和危重肢体缺血)。结果:预测所有年龄段主要终点的c统计量为0.76 (95% CI 0.70 ~ 0.81),观察到的10年事件发生率与预测的相似。然而,仅当使用高风险地区的算法时,观察到的10年次要事件发生率与估计的发生率相似。结论:SCORE2和SCORE2- op中等风险算法在塞浦路斯人群中预测心肌梗死、中风和致命性心血管疾病的10年风险表现良好。然而,所有ASCVD事件的10年风险估计最好通过高风险算法计算。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Angiology
International Angiology 医学-外周血管病
CiteScore
2.80
自引率
28.60%
发文量
89
审稿时长
6-12 weeks
期刊介绍: International Angiology publishes scientific papers on angiology. Manuscripts may be submitted in the form of editorials, original articles, review articles, special articles, letters to the Editor and guidelines. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work. Duties and responsibilities of all the subjects involved in the editorial process are summarized at Publication ethics. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (ICMJE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信